Company news
Fresenius Medical Care AG news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Fresenius Medical Care AG: Shervin J. Korangy, Acquisition (Joint securities account with spouse)
November 20, 2026
Release of a capital market information
November 16, 2026
Fresenius completes sale of 13.4 million Fresenius Medical Care shares at €39.00 per share, raising approximately €524 million
November 12, 2026
Fresenius Medical Care places bond with a volume of 500 million Euros
November 9, 2026
Release of a capital market information
November 9, 2026
Fresenius Medical Care reports third quarter 2026 performance partially offsetting headwinds and narrowing full year outlook
November 3, 2026
Release of a capital market information
October 26, 2026
Fresenius Medical Care AG: Martin Fischer, Acquisition of shares under the Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Allocation 2023)
October 19, 2026
Release of a capital market information
October 19, 2026
Release of a capital market information
October 12, 2026
Change in CEO – Shervin J. Korangy Succeeds Helen Giza
October 7, 2026
Refines China Commercial Strategy with a Focus on Long-Term Growth and Market Leadership
September 25, 2026
Statement Regarding Cybersecurity Incident
September 22, 2026
Fresenius Medical Care Announces Publication of a Multinational Real-World Evidence Study Associating High-Volume Hemodiafiltration with Lower Mortality Risk Than Conventional Hemodialysis
August 27, 2026
Fresenius Medical Care appoints Cassie McLean as new Management Board Member for Care Delivery
August 3, 2026
Fresenius Medical Care accelerates income growth to 23% in the second quarter of 2026 while advancing its strategic agenda
August 3, 2026
Fresenius Medical Care introduces TherapyWiseTM analytics for kidney replacement therapy
July 20, 2026
Fresenius Medical Care: Interwell Health Delivers Strong Quality Scores and Shared Savings in CMS Value-Based Kidney Care Model
June 10, 2026
Fresenius Medical Care launches kinexus worldwide, a unified digital platform to support home dialysis
June 3, 2026
Fresenius Medical Care launches first tranche of its share buyback program of up to EUR 600 million
May 28, 2026
Release of a capital market information
May 28, 2026
Fresenius Medical Care highlights new renal research and innovation at ERA Congress 2026
May 27, 2026
Fresenius Medical Care announces new share buyback program with a total volume of around EUR 1 billion with phased execution over 12 months
May 26, 2026
Fresenius Medical Care AG resolves share buyback program with a total volume of around EUR 1 billion in tranches
May 26, 2026
Fresenius Medical Care Annual General Meeting: Strengthening performance and advancing innovation in kidney care
May 21, 2026
Fresenius Medical Care Reappoints Chief Financial Officer Martin Fischer
May 20, 2026
Reappoints Chief Financial Officer Martin Fischer
May 20, 2026
Fresenius Medical Care delivers strong operating income growth in Q1 2026 while advancing the U.S. rollout of 5008X CAREsystems at speed
May 5, 2026
Fresenius Medical Care AG: Helen Pring Giza, Acquisition of shares under the Fresenius Medical Care Management Board Long Term Incentive Plan 2020 (Allocation 2023)
March 18, 2026
Fresenius Medical Care publishes its Annual Report 2025: The power of care
March 12, 2026
Helen Giza Vorstandsvorsitzende (FME Q4 2025 Transcript)
February 25, 2026
Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band
February 24, 2026
Interwell Health Appoints Dr. Carney Taylor as Chief Medical Officer
January 26, 2026
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned
January 9, 2026
RIS Rx Appoints Stuart McGuigan to Board of Directors
December 17, 2025
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board
December 10, 2025
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025
November 4, 2025
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025
October 30, 2025
Fresenius Medical Care appoints Joseph Turk as new Management Board Member for Care Enablement
October 1, 2025
Fresenius Medical Care advances its FME Reignite strategy by increasing ownership in its Value-Based Care asset and appointing a new leader for the operating segment
September 18, 2025
Fresenius Medical Care announces first tranche of its share buyback program of up to EUR 600 million as part of its new capital allocation framework
August 11, 2025
Fresenius Medical Care delivers strong organic revenue growth and double-digit operating income growth in the second quarter of 2025
August 5, 2025
Fresenius Medical Care's Third-Party Clinical Research Organization Frenova Announces Strategic Collaboration Advancing Genomics-Driven, Precision Kidney Disease Care
July 31, 2025
Fresenius Medical Care Collaborates with Coordination of National Institutes of Health and Specialty Hospital to Extend Access to Innovative Dialysis Therapy in Mexico
July 3, 2025
Opterion Health AG Appoints Industry Leaders Rice Powell and Mark Hahn to Board of Directors
June 23, 2025
Fresenius Medical Care Launches its Strategy FME Reignite with increased Profitability Aspirations, and a New Capital Allocation Framework to further enhance Value Creation
June 17, 2025
Fresenius Medical Care Begins Broader U.S. Commercialization of 5008X™ CAREsystem, Achieves Key Milestones in Efforts to Introduce High-Volume Hemodiafiltration Dialysis Therapy to Individuals with Kidney Disease in the U.S.
June 4, 2025
Fresenius Medical Care presents its new research and innovation for kidney care at European Renal Association Congress 2025
May 30, 2025
Fresenius Medical Care Annual General Meeting: Strong Performance Against Its Strategic Plan Results in Highest Dividend per Share in Its History
May 22, 2025
Fresenius Medical Care starts 2025 with strong organic revenue and income growth
May 6, 2025
Calls
The 5 newest of 25 calls. Every call is listed under its year.
- Fresenius Medical Care (Xetra:FME) Q3 2026 Earnings Call
Nov 3, 2026
Transcript - Fresenius Medical Care (Xetra:FME) Q2 2026 Earnings Call
Aug 4, 2026
Transcript - Fresenius Medical Care (Xetra:FME) Q1 2026 Earnings Call
May 5, 2026
Transcript - Fresenius Medical Care (Xetra:FME) Q4 2025 Earnings Call
Feb 24, 2026
Transcript - Fresenius Medical Care (Xetra:FME) Q3 2025 Earnings Call
Nov 4, 2025
Transcript
Decks
The 5 newest of 158 decks. Every deck is listed under its year.
- Q2 2026 Earnings Presentation
Earnings · 29 slides · Aug 4, 2026
- Q1 2026 Earnings Presentation
Earnings · 47 slides · May 29, 2026
- Q1 2026 Earnings Presentation
Earnings · 26 slides · May 5, 2026
- Q4 2025 Earnings Presentation
Earnings · 38 slides · Feb 24, 2026
- Annual Press Conference 2026
Conference · 22 slides · Feb 24, 2026